Medpace Holdings, Inc. (NASDAQ:MEDP) Executive Vice President of Operations, Susan E. Burwig, recently sold shares of the company stock, according to the latest SEC filings. The transaction involved the sale of 102 shares at an average price of $403.00, totaling over $41,000.
The shares were sold on March 15th, during an open trading window for the company, and were executed through a limit order. The sale price represents a weighted average, with individual transactions occurring at prices ranging from $403.00 to $403.14 per share. Post transaction, Burwig's remaining stake in the company consists of 15,181 shares of common stock.
Investors and the public can request detailed pricing information from the reporting person, as noted in the footnotes of the SEC filing. The disclosed transactions provide insights into the trading activities of Medpace Holdings' executives and can serve as a data point for investors monitoring insider behavior within the company.
InvestingPro Insights
As investors analyze the recent insider selling at Medpace Holdings, Inc. (NASDAQ:MEDP), it's important to consider the broader financial picture of the company. According to real-time data from InvestingPro, Medpace has a market capitalization of approximately $12.0 billion USD. The company's Price-to-Earnings (P/E) ratio stands at 42.27, indicating a valuation that may be considered high relative to the company's earnings. This aligns with an InvestingPro Tip that Medpace is trading at a high earnings multiple, which could suggest that investors have high expectations for the company's future growth.
Furthermore, Medpace's Price-to-Book (P/B) ratio for the last twelve months as of Q4 2023 is 21.46, which reinforces the InvestingPro Tip that the company is trading at a high Price/Book multiple. This metric can be particularly insightful for investors, as it suggests the market is pricing the company's net assets at a significant premium. Additionally, the revenue growth for Medpace has been robust, with the last twelve months as of Q4 2023 showing a 29.17% increase, which may provide some justification for the higher valuation multiples.
For those interested in delving deeper into Medpace's financials and insider activities, InvestingPro offers a comprehensive array of tips and metrics. Currently, there are 18 additional InvestingPro Tips available for Medpace, which can be accessed at https://www.investing.com/pro/MEDP. Investors seeking to make informed decisions may find these tips particularly valuable. To further enhance your investing toolkit, use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at InvestingPro.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.